C-9NYQMorphoceuticals Inc
bioelectrome, multi-omics, AI
repairingsmall molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-9NYQ
C-9NYQC-9NYQbioelectrome, multi-omics, AI
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Morphoceuticals states that biology contains anatomical programming as a core part of a biological operating system, and that bioelectric methods can access and reprogram this system. The company says it uses proprietary combinations of ion channel and gap junction modulators to induce limb regeneration, improve amputation stump health, promote organ regeneration, and treat channelopathies.
SourceMorphoceuticals states that biology is a programmable living system whose code can be altered through bioelectric reprogramming. The company believes known ion-channel drugs, including many already approved for human use, can be used to modify electric potentials in cells and tissues to enable regenerative medicine applications, including improving amputation stump health, supporting limb regeneration, advancing organogenesis, and building a bioelectric atlas to correct numerous disease indications.
SourceThe provided visible text contains only Internet Archive and Archive Team interface/collection copy, not substantive content from MorphoCeuticals itself. Based on this snapshot text alone, no company-specific beliefs, mission, or scientific/longevity theories can be extracted.
Source